.In this full week's episode of "The Best Line," our company are actually diving in to Ferocious Bio...
.The confetti is still soaring from Eli Lilly's celebration celebrating the approval of Alzheimer's ...
.Welcome to today's Chutes & Ladders, our summary of substantial leadership hirings, shootings an...
.Following an unsatisfactory presenting for Lykos Therapeutics' MDMA prospect for trauma at a recent...
.AN2 Therapeutics is reviewing its organization in feedback to uninspired midphase information, swea...
.Merck & Co. is spending $700 million beforehand to challenge Amgen in a blood cancer market. The...
.With Gilead Sciences about to an FDA decision for its own liver ailment drug seladelpar, the firm h...
.CEO David Ricks can easily observe the firms putting together outdoors tents at basecamp responsibl...
.Bed Liquidators has actually switched Entero Therapeutics white as a piece. The financial instituti...
.Exelixis is giving up on its own tissue factor (TF)- targeting antibody-drug conjugate after conclu...